Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas

Updated on: December 22,2023

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas

Updated on:December 22,2023

Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on: February 18,2024

Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on:February 18,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on: September 03,2024

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on:September 03,2024

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to

Updated on: April 30,2024

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to

Updated on:April 30,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Updated on: March 24,2024

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Updated on:March 24,2024

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on: August 27,2024

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on:August 27,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on: August 27,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on:August 27,2024

Genetic tests create treatment opportunities and confusion for breast cancer patients

by Michelle AndrewsCredit: Pixabay/CC0 Public DomainThe past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been diagnosed with breast c

Updated on: December 25,2023

Genetic tests create treatment opportunities and confusion for breast cancer patients

by Michelle AndrewsCredit: Pixabay/CC0 Public DomainThe past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been diagnosed with breast c

Updated on:December 25,2023

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on: July 11,2024

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on:July 11,2024